Outsourced Data Protection Officer service, within healthcare sector

Outsourcing the DPO function for companies and organizations in the healthcare sector.

Offer details :

Goal: to benefit from external support in setting up and sustain your data protection compliance policy.

Compliance and permanent control

Evaluation of compliance and definition of the action plan
Core tasks
- Procedures for appointment as DPO of the client with the CNIL* (French Data Protection Authority)
- Regular video calls
- Legislative and regulatory watch each month
- Preparation of the annual activity report

Additional tasks according to identified specific needs.

Training and awareness

Providing trainings or awareness sessions for your team in the short format (2h00) face-to-face or in remote on the subject of compliance with principles related to protection of personal data.
Design and development of e-learning sessions in various modules up to 4-5 minutes for all members of the customer’s staff on the subject of compliance with principles related to protection of personal data.

Compliance management and monitoring of the DPO mandate

Operating on the shared platform with the aim to co-manage compliance regarding our customers’ data protection policies.

Prices

Annual subscription is determined based on activities and volume of data processed by the company and different options included (use of the platform, awareness sessions, etc.).

Illustration :

Mise en place d’une étude de suivi clinique après commercialisation d’un dispositif médical
10 centres : 4 hôpitaux publics + 6 cliniques

Coût par contrat signé ou exécuté: 350 €

Total : 3500 €

Discover our other offers

Outsourcing the contracting service with health institutions or professionals

PIA (Privacy Impact Assessment) in clinical research

Externalisation de la fonction de DPO (Data Protection Officer) pour les start-up spécialisées dans la e-santé - à supprimer

PIA en recherche clinique Rédaction d’Analyse d’Impact sur la Protection des Données (AIPD / PIA) pour les traitements mis en œuvre dans le cadre des recherches cliniques (MR-001, MR-003 et MR-004)